Weekly Reports | Nov 15 2024
This story features DOMAIN HOLDINGS AUSTRALIA LIMITED, and other companies. For more info SHARE ANALYSIS: DHG
Broker Rating Changes (Post Thursday Last Week)
Upgrade
DOMAIN HOLDINGS AUSTRALIA LIMITED ((DHG)) Upgrade to Buy from Overweight by Jarden.B/H/S: 0/0/0
Domain Holdings Australia and REA Group’s quarterly updates showed similar paid volumes growth, Jarden notes, however this is where the similarities ended.
The impact of winbacks diluted Domain’s controllable yield growth while REA’s Buy yield grew by an “impressive” 15%.
The broker suggests this indicates REA is growing its share of agent spend, although agent spend is growing overall, which still benefits Domain.
Jarden has downgraded forecast earnings for Domain and upgraded REA’s, cutting Domain’s target by-2.9% to $3.35 and lifting REA’s target 2.3% to $181.
Domain’s share price underperformance is considered an opportunity and the broker upgrades to Buy from Overweight. Jarden moves REA to Underweight from Sell despite its stronger operating momentum but notes a lack of near-term catalyst.
REA GROUP LIMITED ((REA)) Upgrade to Underweight from Sell by Jarden.B/H/S: 0/0/0
Domain Holdings Australia and REA Group’s quarterly updates showed similar paid volumes growth, Jarden notes, however this is where the similarities ended.
The impact of winbacks diluted Domain’s controllable yield growth while REA’s Buy yield grew by an impressive 15%.
This indicates REA is growing its share of agent spend, the broker suggests, although agent spend is growing overall, which still benefits Domain.
Jarden has downgraded forecast earnings for Domain and upgraded REA’s, cutting Domain’s target by-2.9% to $3.35 and lifting REA’s target 2.3% to $181.
Domain’s share price underperformance is considered an opportunity and the broker upgrades to Buy from Overweight. Jarden moves REA to Underweight from Sell, ignoring its stronger operating momentum but notes a lack of near-term catalyst.
Downgrade
ENDEAVOUR GROUP LIMITED ((EDV)) Downgrade to Neutral from Overweight by Jarden.B/H/S: 0/0/0
Jarden has downgraded Endeavour Group to Neutral from Overweight, citing a challenging outlook for the company as Q1 retail sales were flat and Q2 is expected to decline.
The broker expects 2Q retail margins to fall by -50 to -100bps year-on-year due to increased competition and promotional activity, while a lack of significant catalysts limits near-term growth opportunities.
With the recent CEO change, the analysts express concern over long-term execution, especially with rising operational costs and new ERP implementation pressures.
Jarden reduces its target price to $5.00 from $6.00, reflecting uncertainty and a cautious stance on retail and liquor market trends. Neutral.
HARVEY NORMAN HOLDINGS LIMITED ((HVN)) Downgrade to Sell from Neutral by Goldman Sachs.B/H/S: 0/0/0
Goldman Sachs has downgraded Harvey Norman to Sell from Neutral, reducing the target price to $4.00 from $4.50 ahead of the company’s trading update.
The downgrade is based on the broker’s expectations of market share losses in A&NZ due to increased competition from JB Hi-Fi ((JBH)) and Officeworks ((WES)), as well as lower anticipated earnings.
The broker’s forecast earnings sit below consensus estimates by -8% to -13% for FY25 to FY27.
Goldman Sachs has revised valuation multiples down for A&NZ franchises and raised the cap rate for property valuation to 6.25%, citing a challenging macro environment.
LIONTOWN RESOURCES LIMITED ((LTR)) Downgrade to Hold from Buy by Petra Capital.B/H/S: 0/0/0
Following an optimisation study, Petra Capital highlights Liontown Resources has lowered its long-term processing rate to 2.8Mtpa, reducing expected output to 530ktpa by FY28 from a previous estimate of 560ktpa.
Separately, the ramp-up at Kathleen Valley is progressing well, with guidance for FY25 production now at 275kt (midpoint) compared to the broker’s previous assumption of 198kt.
Due to lower output and lower feed grade, the broker assumes higher unit costs over the coming years, reducing the target to 85c from $1.10. The rating is downgraded to Hold from Buy.
SILK LOGISTICS HOLDINGS LIMITED ((SLH)) Downgrade to Hold from Buy by Moelis.B/H/S: 0/0/0
Moelis notes Silk Logistics has entered into a binding Scheme Implementation Deed with DP World Australia for the proposed acquisition of 100% of the company’s shares at $2.14.
The offer values the company at $174.5m, a significant premium to recent trading, the analyst notes, and Silk Logistics’ board is recommending shareholders vote in favour of the proposal in the absence of a better offer.
No changes to the analyst’s earnings forecasts.
The stock is downgraded to Hold from Buy with a higher target price of $2.14.
| Order | Company | New Rating | Old Rating | Broker | |
|---|---|---|---|---|---|
| Upgrade | |||||
| 1 | DOMAIN HOLDINGS AUSTRALIA LIMITED | Buy | Buy | Jarden | |
| 2 | REA GROUP LIMITED | Sell | Sell | Jarden | |
| Downgrade | |||||
| 3 | ENDEAVOUR GROUP LIMITED | Neutral | Buy | Jarden | |
| 4 | HARVEY NORMAN HOLDINGS LIMITED | Sell | Neutral | Goldman Sachs | |
| 5 | LIONTOWN RESOURCES LIMITED | Neutral | Buy | Petra Capital | |
| 6 | SILK LOGISTICS HOLDINGS LIMITED | Neutral | Buy | Moelis | |
Price Target Changes (Post Thursday Last Week)
| Company | Last Price | Broker | New Target | Old Target | Change | |
|---|---|---|---|---|---|---|
| ACF | Acrow | $1.09 | Moelis | 1.41 | 1.08 | 30.56% |
| AGE | Alligator Energy | $0.04 | Petra Capital | 0.10 | 0.11 | -9.09% |
| ALL | Aristocrat Leisure | $67.18 | Goldman Sachs | 70.00 | 55.30 | 26.58% |
| ARB | ARB Corp | $41.48 | Goldman Sachs | 39.20 | 40.00 | -2.00% |
| ASK | Abacus Storage King | $1.19 | Moelis | 1.38 | 1.34 | 2.99% |
| AVH | Avita Medical | $3.96 | Wilsons | 3.20 | 2.75 | 16.36% |
| BMN | Bannerman Energy | $2.76 | Petra Capital | 4.51 | 4.68 | -3.63% |
| CNB | Carnaby Resources | $0.39 | Petra Capital | 1.45 | 1.53 | -5.23% |
| COI | Comet Ridge | $0.17 | Canaccord Genuity | 0.21 | 0.17 | 23.53% |
| DHG | Domain Holdings Australia | $2.79 | Goldman Sachs | 3.20 | 3.40 | -5.88% |
| Jarden | 3.35 | 3.45 | -2.90% | |||
| DMP | Domino’s Pizza Enterprises | $28.46 | Goldman Sachs | 39.10 | 40.00 | -2.25% |
| EDV | Endeavour Group | $4.24 | Goldman Sachs | 5.50 | 6.20 | -11.29% |
| Jarden | 5.00 | 6.00 | -16.67% | |||
| GLL | Galilee Energy | $0.01 | Canaccord Genuity | 0.03 | 0.08 | -62.50% |
| HVN | Harvey Norman | $4.53 | Goldman Sachs | 4.00 | 4.50 | -11.11% |
| IFM | Infomedia | $1.30 | Moelis | 1.83 | 1.88 | -2.66% |
| IPH | IPH | $5.20 | Petra Capital | 8.25 | 8.20 | 0.61% |
| IPL | Incitec Pivot | $3.01 | Goldman Sachs | 3.35 | 3.30 | 1.52% |
| IPX | Iperionx | $3.75 | Petra Capital | 5.01 | 4.93 | 1.62% |
| JBH | JB Hi-Fi | $87.95 | Goldman Sachs | 66.90 | 54.40 | 22.98% |
| JHX | James Hardie Industries | $55.00 | Goldman Sachs | 57.85 | 55.00 | 5.18% |
| JIN | Jumbo Interactive | $12.66 | Jarden | 14.60 | 14.70 | -0.68% |
| Wilsons | 14.14 | 15.89 | -11.01% | |||
| LAU | Lindsay Australia | $0.90 | Wilsons | 1.24 | 1.22 | 1.64% |
| LIC | Lifestyle Communities | $8.74 | Goldman Sachs | 9.95 | 11.30 | -11.95% |
| LOT | Lotus Resources | $0.23 | Canaccord Genuity | 0.42 | 0.54 | -22.22% |
| LTM | Arcadium Lithium | $8.05 | Goldman Sachs | 8.22 | 6.35 | 29.45% |
| LTR | Liontown Resources | $0.86 | Goldman Sachs | 0.87 | 0.95 | -8.42% |
| Petra Capital | 0.85 | 1.10 | -22.73% | |||
| MAQ | Macquarie Technology | $89.72 | Petra Capital | 94.93 | 87.81 | 8.11% |
| NEC | Nine Entertainment | $1.14 | Goldman Sachs | 1.65 | 1.90 | -13.16% |
| Jarden | 1.55 | 1.60 | -3.13% | |||
| NEU | Neuren Pharmaceuticals | $17.30 | Wilsons | 30.94 | N/A | – |
| NHF | nib Holdings | $5.71 | Goldman Sachs | 6.75 | 6.60 | 2.27% |
| Jarden | 7.20 | 6.25 | 15.20% | |||
| PER | Percheron Therapeutics | $0.08 | Wilsons | 0.25 | 0.27 | -7.41% |
| PFP | Propel Funeral Partners | $5.80 | Moelis | 6.20 | 6.01 | 3.16% |
| PXA | Pexa Group | $13.44 | Goldman Sachs | 16.00 | 16.20 | -1.23% |
| Jarden | 14.65 | 14.90 | -1.68% | |||
| REA | REA Group | $245.51 | Goldman Sachs | 249.00 | 245.00 | 1.63% |
| Jarden | 181.00 | 177.00 | 2.26% | |||
| SLH | Silk Logistics | $2.07 | Moelis | 2.14 | 1.67 | 28.14% |
| SUN | Suncorp Group | $18.84 | Goldman Sachs | 19.20 | 18.50 | 3.78% |
| Jarden | 17.50 | 17.35 | 0.86% | |||
| SWM | Seven West Media | $0.16 | Goldman Sachs | 0.13 | 0.14 | -7.14% |
| TLC | Lottery Corp | $5.07 | Jarden | 5.00 | 5.10 | -1.96% |
| WDS | Woodside Energy | $23.65 | Goldman Sachs | 26.20 | 27.20 | -3.68% |
| Company | Last Price | Broker | New Target | Old Target | Change | |
More Highlights
ACF ACROW LIMITED
Building Products & Services Overnight Price: $1.10
Moelis rates ((ACF)) as Buy (1)
Moelis highlights secured hire contracts have increased by 57% year-on-year, reaching $33.8m, supported by high demand in the Screens and Jumpform divisions, particularly in projects like Ipswich and Toowoomba hospitals for Acrow.
The company’s pipeline has grown to a record $198m as of October 2024, up 39% from the previous year, indicating robust demand.
Moelis makes slight EPS adjustments for FY2527 due to Industrial Access growth, partially offset by lower group margins.
The broker believes the Queensland civil and commercial projects are expected to underpin formwork growth.
Buy rating unchanged with target lifted to $1.41 from $1.38.
This report was published on November 12, 2024.
Target price is $1.41 Current Price is $1.10 Difference: $0.31
If ACF meets the Moelis target it will return approximately 28% (excluding dividends, fees and charges).
Current consensus price target is $1.30, suggesting upside of 16.8%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY25:
Moelis forecasts a full year FY25 dividend of 6.00 cents and EPS of 11.90 cents.
At the last closing share price the estimated dividend yield is 5.45%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 9.24.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 11.7, implying annual growth of 31.9%.
Current consensus DPS estimate is 5.7, implying a prospective dividend yield of 5.1%.
Current consensus EPS estimate suggests the PER is 9.5.
Forecast for FY26:
Moelis forecasts a full year FY26 dividend of 6.40 cents and EPS of 12.90 cents.
At the last closing share price the estimated dividend yield is 5.82%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 8.53.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 12.2, implying annual growth of 4.3%.
Current consensus DPS estimate is 6.0, implying a prospective dividend yield of 5.4%.
Current consensus EPS estimate suggests the PER is 9.1.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
ARX AROA BIOSURGERY LIMITED
Pharmaceuticals & Biotech/Lifesciences Overnight Price: $0.68
Canaccord Genuity rates ((ARX)) as Buy (1)
Aroa Biosurgery’s distributor of Ovitex and Ovitex PRS product lines, TELA, released its Sep Q result that slightly beat Canaccord Genuity’s expectations, and maintained 2024 guidance.
The quarter showed a bounce-back back following a challenged June Q of cyberattacks, procedure volume weakness, and surgeon user departure, the broker notes. The company reported 26% revenue growth, with strong European growth.
Aroa continues to look cheap in Canaccord’s view, with this year expected to be its maiden profitable year. The broker expects operating leverage and scale to come through in FY26, which should help restore investor confidence in the company.
Buy and $1.00 target retained.
This report was published on November 11, 2024.
Target price is $1.00 Current Price is $0.68 Difference: $0.32
If ARX meets the Canaccord Genuity target it will return approximately 47% (excluding dividends, fees and charges).
The company’s fiscal year ends in March.
Forecast for FY25:
Canaccord Genuity forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 0.37 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 184.78.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 1.93 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 35.21.
This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
AVA AVA RISK GROUP LIMITED
Hardware & Equipment Overnight Price: $0.14
Canaccord Genuity rates ((AVA)) as Buy (1)
Ava Risk’s 1Q25 update showed order intake of $8.9m, sustaining a strong backlog and supporting FY25 revenue guidance of $42.7$55.2m, implying a “substantially stronger” second half, Canaccord Genuity observes.
The analyst notes Detect remains the key revenue driver, estimated to contribute $29m for FY25, a 58% increase year-on-year. The pipeline for Direct applications is highlighted by the broker as over $100m in opportunities.
Management attributes AVA’s growth to improved processes, product offerings, and reduced competition. Buy rating retained with 30c target price.
This report was published on November 6, 2024.
Target price is $0.30 Current Price is $0.14 Difference: $0.16
If AVA meets the Canaccord Genuity target it will return approximately 114% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY25:
Canaccord Genuity forecasts a full year FY25 dividend of 0.00 cents and EPS of 1.30 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 10.77.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.85 cents and EPS of 3.10 cents.
At the last closing share price the estimated dividend yield is 6.07%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 4.52.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
DUR DURATEC LIMITED
Industrial Sector Contractors & Engineers Overnight Price: $1.60
Taylor Collison rates ((DUR)) as Initiation of coverage with Outperform (2)
Taylor Collison initiates coverage on Duratec with an Outperform rating, noting the company’s unique position as a remediation-focused contractor within sectors such as defence, mining, and energy.
The broker suggests the defence sector operations (comprising around 40% of revenue) are a significant advantage, given the long-term government investment in Australian defence infrastructure.
Duratec’s proprietary MEnD Consulting division provides additional differentiation, suggests the analyst, enhancing margins and generating cross-selling opportunities through its durability engineering services.
Taylor Collison forecasts revenue growth supported by major contracts, including projects with Rio Tinto ((RIO)) and BHP Group ((BHP)).
It’s anticipated gross margins will improve as management decreases reliance on subcontractors in favour of internal capabilities.
The current valuation is attractive, in Taylor Collison’s view, given the industry fundamentals and the company’s growth trajectory.
Taylor Collison sets a price target of $1.87.
This report was published on November 8, 2024.
Target price is $1.87 Current Price is $1.60 Difference: $0.27
If DUR meets the Taylor Collison target it will return approximately 17% (excluding dividends, fees and charges).
Current consensus price target is $1.64, suggesting upside of 4.2%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY25:
Taylor Collison forecasts a full year FY25 dividend of 6.10 cents and EPS of 9.80 cents.
At the last closing share price the estimated dividend yield is 3.81%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 16.33.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 10.7, implying annual growth of 23.6%.
Current consensus DPS estimate is 4.8, implying a prospective dividend yield of 3.1%.
Current consensus EPS estimate suggests the PER is 14.7.
Forecast for FY26:
Taylor Collison forecasts a full year FY26 dividend of 8.20 cents and EPS of 10.80 cents.
At the last closing share price the estimated dividend yield is 5.12%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 14.81.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 12.5, implying annual growth of 16.8%.
Current consensus DPS estimate is 6.1, implying a prospective dividend yield of 3.9%.
Current consensus EPS estimate suggests the PER is 12.6.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
IPH IPH LIMITED
Legal Overnight Price: $5.27
Petra Capital rates ((IPH)) as Buy (1)
IPH’s patent filings data for October indicate weak national phase filings, according to Petra Capital, a trend persisting since May, with IPH’s filings down -4.7% year-on-year compared to the market at -3.3%.
The broker attributes part of this decline to the company’s higher exposure to the US market, where demand has softened.
In the six-month period to October, IPH’s filings decreased by -8.5% versus the market’s -3.9%, yet growth in direct filings mitigated the impact, explains the analyst.
Rolling 12-month data reflect a market share of 31.5%, a level maintained since May 2023, notes Petra Capital.
The broker maintains a Buy rating with an unchanged target price of $8.25.
This report was published on November 12, 2024.
Target price is $8.25 Current Price is $5.27 Difference: $2.98
If IPH meets the Petra Capital target it will return approximately 57% (excluding dividends, fees and charges).
Current consensus price target is $7.65, suggesting upside of 44.9%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY25:
Petra Capital forecasts a full year FY25 dividend of 35.30 cents and EPS of 46.40 cents.
At the last closing share price the estimated dividend yield is 6.70%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 11.36.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 46.8, implying annual growth of 86.6%.
Current consensus DPS estimate is 36.4, implying a prospective dividend yield of 6.9%.
Current consensus EPS estimate suggests the PER is 11.3.
Forecast for FY26:
Petra Capital forecasts a full year FY26 dividend of 37.50 cents and EPS of 49.20 cents.
At the last closing share price the estimated dividend yield is 7.12%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 10.71.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 50.3, implying annual growth of 7.5%.
Current consensus DPS estimate is 37.5, implying a prospective dividend yield of 7.1%.
Current consensus EPS estimate suggests the PER is 10.5.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
LAU LINDSAY AUSTRALIA LIMITED
Transportation & Logistics Overnight Price: $0.92
Wilsons rates ((LAU)) as Overweight (1)
Lindsay Australia’s 1H25 trading update shows continued recovery in the horticulture market, with transport revenue up 3.5% and commercial volumes growing by 5% year-on-year despite weaker-than-expected sales updates from Coles and Woolworths, Wilsons observes.
Rural sales also rose by 3.5%, suggesting a positive outlook for future horticultural volumes.
The broker’s earnings forecasts remain largely unchanged.
Target price lifts to $1.24 from $1.22. Overweight rating unchanged.
This report was published on November 11, 2024.
Target price is $1.24 Current Price is $0.92 Difference: $0.32
If LAU meets the Wilsons target it will return approximately 35% (excluding dividends, fees and charges).
Current consensus price target is $1.21, suggesting upside of 30.5%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY25:
Wilsons forecasts a full year FY25 dividend of 4.50 cents and EPS of 10.90 cents.
At the last closing share price the estimated dividend yield is 4.89%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 8.44.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 10.6, implying annual growth of 21.1%.
Current consensus DPS estimate is 5.0, implying a prospective dividend yield of 5.4%.
Current consensus EPS estimate suggests the PER is 8.8.
Forecast for FY26:
Wilsons forecasts a full year FY26 dividend of 5.70 cents and EPS of 13.50 cents.
At the last closing share price the estimated dividend yield is 6.20%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 6.81.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 11.8, implying annual growth of 11.3%.
Current consensus DPS estimate is 5.3, implying a prospective dividend yield of 5.7%.
Current consensus EPS estimate suggests the PER is 7.9.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
MYX MAYNE PHARMA GROUP LIMITED
Pharmaceuticals & Biotech/Lifesciences Overnight Price: $5.30
Canaccord Genuity rates ((MYX)) as Buy (1)
Media speculation on the potential for acquisition of Mayne Pharma comes as no surprise to Canaccord Genuity.
The broker comments new management has proven its ability to execute across Women’s Health and Dermatology, and has worked well to restore investor confidence in the longer-term sustainable growth story that was previously elusive.
The turnaround story “has legs”, and Canaccord believes the stock still trades well below underlying value and at a material discount to. peers. This could potentially represent an attractive, accretive opportunity for a larger player in the specialty pharma space.
Buy and $6.25 target retained.
This report was published on November 11, 2024.
Target price is $6.25 Current Price is $5.30 Difference: $0.95
If MYX meets the Canaccord Genuity target it will return approximately 18% (excluding dividends, fees and charges).
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
PXA PEXA GROUP LIMITED
Real Estate Overnight Price: $13.41
Goldman Sachs rates ((PXA)) as Buy (1)
Goldman Sachs notes Pexa Group’s 1Q25 trading update showed strong transfer growth, up 14%, indicating a recovery in the property market and setting the stage for revenue to hit the high end of FY25 guidance.
The broker expects FY25 revenue growth of 13-19%, with an operating earnings (EBITDA) margin above 34%, although some challenges persist due to delayed testing for PEXA Pay in the UK, now anticipated for 3Q25.
The shift in PEXA Pay timelines impacts the broader UK roll-out, yet lender engagement remains positive, supporting the broker’s optimism for future adoption.
Goldman Sachs lowers its target price to $16.00 from $16.20 and maintains a Buy rating.
This report was published on November 12, 2024.
Target price is $16.00 Current Price is $13.41 Difference: $2.59
If PXA meets the Goldman Sachs target it will return approximately 19% (excluding dividends, fees and charges).
Current consensus price target is $15.80, suggesting upside of 17.1%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY25:
Goldman Sachs forecasts a full year FY25 dividend of 0.00 cents and EPS of 9.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 149.00.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 27.9, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 48.4.
Forecast for FY26:
Goldman Sachs forecasts a full year FY26 dividend of 0.00 cents and EPS of 26.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 51.58.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 39.8, implying annual growth of 42.7%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 33.9.
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
Click to view our Glossary of Financial Terms
CHARTS
For more info SHARE ANALYSIS: DHG - DOMAIN HOLDINGS AUSTRALIA LIMITED
For more info SHARE ANALYSIS: EDV - ENDEAVOUR GROUP LIMITED
For more info SHARE ANALYSIS: HVN - HARVEY NORMAN HOLDINGS LIMITED
For more info SHARE ANALYSIS: JBH - JB HI-FI LIMITED
For more info SHARE ANALYSIS: LTR - LIONTOWN RESOURCES LIMITED
For more info SHARE ANALYSIS: REA - REA GROUP LIMITED
For more info SHARE ANALYSIS: SLH - SILK LOGISTICS HOLDINGS LIMITED
For more info SHARE ANALYSIS: WES - WESFARMERS LIMITED